Additionally, single-gene AS events were evaluated in STS by Jacob et al. [45]; their research irrefutably identified specific alternative splice variants of MDM2 and MDM4 as persistent biomarkers of rhabdomyosarcoma (RMS) tumors. This evidence concerns the gene MDM2 and rhabdomyosarcoma.